Human Anti-CD33 Recombinant Antibody (clone huM195) (CAT#: FAMAB-0045CQ)

Recombinant Human Antibody clone huM195, which is specific to CD33. The humanized M195 antibody, which has reshaped V regions, have higher apparent binding affinity for the CD33 Ag than the chimeric or mouse antibodies.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
FuncS

Figure 1 Overall survival analysis: HuM195 (lintuzumab) -treated versus control patients

Figure 1 Overall survival analysis: HuM195 (lintuzumab) -treated versus control patients

Feldman, E. J., Brandwein, J., Stone, R., Kalaycio, M., Moore, J., O'Connor, J., ... & Jurcic, J. C. (2005). Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia. Journal of Clinical Oncology, 23(18), 4110-4116.


Specifications

  • Host Species
  • Human
  • Derivation
  • Humanized
  • Type
  • Humanized IgG1
  • Specificity
  • Human CD33
  • Species Reactivity
  • Human
  • Clone
  • huM195
  • Applications
  • ELISA, FC, FuncS
  • Related Disease
  • AML

Product Property

  • Purity
  • >95% as determined by SDS-PAGE and HPLC analysis
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • This antibody has been tested for use in Functional Assay.

Target

  • Alternative Names
  • CD33 Molecule; Sialic Acid Binding Ig-Like Lectin 3; Sialic Acid-Binding Ig-Like Lectin 3; CD33 Antigen (Gp67); SIGLEC-3; SIGLEC3; Gp67; CD33 Antigen; P67

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone HuM195"

See other products for "CD33"

Select a product category from the dropdown menu below to view related products.
Please select product type
Single-domain Antibody Humanized Antibody Immunotoxin Human Antibody Mouse Antibody Fab Glycosylation Blocking Antibody Rabbit Monoclonal Antibody Chimeric Antibody MHC Tetramer for Cancer scFv Fragment Antibody Recombinant Antibody ADCC Enhanced Antibody Fab Fragment Antibody
CAT Product Name Application Type
NAB-321-sdAb Recombinant Anti-human CD33 VHH Single Domain Antibody WB, IP, ChiP, Neut, ELISA Llama VHH

Customer Reviews and Q&As

Customer Review Q&As

Submit a review or a question

  • High satisfaction
    My satisfaction with the Human Anti-CD33 Recombinant Antibody (clone huM195) is very high.
  • Effective and manageable
    The Human Anti-CD33 Recombinant Antibody (clone huM195) has been both effective and manageable in treating AML.
  • Superior option
    The Human Anti-CD33 Recombinant Antibody (clone huM195) has proven to be a superior treatment option for AML. It effectively targets cancer cells, reducing the side effects at the same time.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare